Business Context and Reporting Period
Company: Torchmark Corporation (Note: Metadata referenced "Globe Life Inc.", but the filing text identifies the registrant as Torchmark Corporation).
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2009
Business Overview: Torchmark is a holding company for life insurance subsidiaries marketing individual life and supplemental health insurance products, primarily to middle-income Americans through niche distribution systems (Direct Response, Independent, and Captive/Career agencies). The company also manages a significant investment portfolio to support policy liabilities.
Key Financial Metrics (Nine Months Ended Sept 30, 2009)
| Metric | 2009 (Unaudited) | 2008 (Unaudited) |
|---|---|---|
| Total Revenue | $2,414,226 | $2,486,277 |
| Net Income | $291,624 | $315,050 |
| Diluted EPS | $3.51 | $3.49 |
| Net Investment Income | $506,005 | $503,763 |
| Realized Investment Gains (Losses) | $17,026 | $(3,784) |
| Other-Than-Temporary Impairments (OTTI) | $(161,755) | $(106,099) |
| Cash Flow from Operations | $588,751 | $613,881 |
| Total Assets | $15,849,970 | $13,529,050 |
| Total Liabilities | $12,534,711 | $11,306,143 |
| Shareholders' Equity | $3,315,259 | $2,222,907 |
| Long-Term Debt | $795,846 | $499,049 |
| Short-Term Debt | $233,410 | $403,707 |
Note: All dollar amounts in thousands except per share data.
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased 3% year-over-year, driven primarily by a 10% decline in health premiums ($776M vs $862M) due to increased competition and agent turnover in the United American Branch Office Agency. Life premiums increased 2% to $1.24B.
- Net Income: Net income decreased 7% to $292M. Despite a 59% increase in net income for the quarter ended Sept 30, the nine-month period was impacted by significant investment writedowns.
- Investment Impairments: Other-than-temporary impairments (OTTI) increased significantly to $162M (pre-tax) in 2009 compared to $106M in 2008. This included writedowns on Collateralized Debt Obligations (CDOs) and corporate bonds. Under new accounting guidance, a portion of these losses ($26M) was recorded in Other Comprehensive Income rather than Net Income.
- Equity Growth: Shareholders' equity increased by approximately $1.1B (49%) compared to the prior year-end, largely due to a $635M reduction in net unrealized losses on the fixed-maturity portfolio as market values recovered from 2008 lows.
- Debt Structure: Long-term debt increased by $297M following the issuance of $300M in 9.25% Senior Notes in June 2009. Proceeds were used to repay $99M in maturing debentures and to contribute capital to insurance subsidiaries.
Guidance, Outlook, and Management Commentary
- Investment Outlook: Management expects the fixed-maturity portfolio to be fully recoverable. The company sold $315M of below-investment-grade securities in Q3 to improve credit quality and risk-based capital ratios. The portfolio yield on new investments was 6.71% in the first nine months of 2009.
- Health Segment Strategy: The company is consolidating the United American Branch Office Agency with the Liberty National Exclusive Agency to address agent turnover and improve product mix. Health net sales (excluding Part D) declined 47% due to competition and agent attrition.
- Capital Resources: The company maintains a target Risk-Based Capital (RBC) ratio of at least 300%. In Q3 2009, the Parent Company contributed $125M to subsidiaries to maintain this ratio following rating downgrades in the investment portfolio. Management expects the ratio to remain above 300% at year-end.
- Share Repurchases: The share repurchase program was suspended in Q1 2009 due to economic conditions. No repurchases were made in Q3. The company does not anticipate acquisitions for the remainder of 2009.
- Medicare Part D: Premiums increased 5% to $139M. Management expects full-year benefit ratios to align with pricing, with interim GAAP differences expected to resolve by year-end.
Investor Verification Checklist
- OTTI Accounting Treatment: Verify the bifurcation of impairment losses between Net Income (credit loss) and Other Comprehensive Income (non-credit loss) under the new FASB guidance adopted in 2009.
- Below-Investment-Grade Exposure: Confirm the current percentage of below-investment-grade securities (10% at amortized cost) and the impact of recent sales on the portfolio's credit quality.
- Health Segment Agent Turnover: Assess the long-term impact of the 51% decline in agents at the United American Branch Office Agency on future health premium growth.
- Capital Injections: Monitor the $125M capital contribution to subsidiaries and the planned $50M purchase of surplus notes to ensure RBC ratios remain above the 300% target.
- Unrealized Losses: Review the $396M in net unrealized losses on fixed maturities and management's assertion that these are temporary and recoverable given the intent to hold to maturity.